Director, Clinical Operations
Cogent Biosciences
Waltham, Massachusetts, United States
Kevin Moynihan is a Director in Clinical Operations and Development at Cogent Biosciences and the Clinical Operations Lead for the Peak Study (CGT9486-21-301). Kevin has worked across numerous therapeutic areas as a clinical research professional, including dermatology, ophthalmology, rare diseases of the central nervous system, and oncology. Kevin has been with Cogent Biosciences since August 2021 and values all the opportunities he's had to support the development of novel therapies for patients and families in need.
Disclosure information not submitted.
